[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Correction
November 17, 2004

Diagnosis of Intra-amniotic Infection by Proteomic Profiling and Identification of Novel Biomarkers

JAMA. 2004;292(19):2340. doi:10.1001/jama.292.19.2340

Financial Disclosure Omitted: In the Preliminary Communication entitled “Diagnosis of Intra-amniotic Infection by Proteomic Profiling and Identification of Novel Biomarkers” published in the July 28, 2004, issue of JAMA (2004;292:462-469), a financial disclosure was omitted. Oregon Health and Science University (OHSU), Drs Gravett, Rosenfeld, Reddy, Jacob, Roberts, and Nagalla and Mr Turner all have a significant financial interest in Proteogenix Inc, a company that may have a commercial interest in the results of this research and technology. Among the 3 investigators involved in statistical analysis of the study (Drs Gravett, Lapidus, and Hitti), the latter 2 have no potential financial interest in the results of this research. This potential conflict of interest has been reviewed and a management plan approved by the OHSU Conflict of Interest in Research Committee, and the Integrity Program Oversight Council has been implemented.

×